Carpal tunnel syndrome, unspecified upper limb. Carpal tunnel syndrome, unspecified upper limb
Conditions
Interventions
Intervention 1: Intervention group 1: Injection of 100 mg lidocaine diluted with normal saline with a volume of 20 ml in the desired hand. Intervention 2: Intervention group 2: Injection of 100 mg of
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: All patients with carpal tunnel syndrome candidate for surgery
Exclusion criteria
Exclusion criteria: Emergency operation Class ASA ?,? Sensitivity to NSAIDs Psychological disorders Heart failure Renal failure Liver failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset of pain after opening the tourniquet. Timepoint: Measure of onset of pain 1 and 24 hours after opening the tourniquet. Method of measurement: Hour.;Quality of analgesia. Timepoint: Measure of Quality of analgesia 1 and 24 hours after opening the tourniquet. Method of measurement: visual analogue scale.;The amount of received analgesic. Timepoint: Measuring the amount of received analgesic within surgery and 1, 24 hours after surgery. Method of measurement: Dosage (mg).;Changes in blood pressure. Timepoint: Recording of changes in blood pressure within surgery and 1, 24 hours after surgery. Method of measurement: Sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSafa Farokhtabar
Babol University of Medical Sciences
Outcome results
None listed